2’-Deoxy-5-fluorocytidine |
D353-904D |
10356-76-0 |
C9H12FN3O4 |
>98% |
5-Fluoro-2’-deoxycytidine; FCDR; FdCyd; NSC-48006 |
5-Azacytidine |
D353-904 |
320-67-2 |
C8H12N4O5 |
>98% (TLC) |
4-Amino-1-(beta-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one, Ladakamycin |
AK-7 |
S36-904 |
420831-40-9 |
C19H21BrN2O3S |
98% (TLC) |
N-(3-Bromophenyl)-3-[(hexahydro-1H-azepin-1-yl)sulfonyl]benzamide |
APICIDIN |
H83-904B |
183506-66-3 |
C34H49N5O6 |
≥98% |
Cyclo[(2S)-2-Amino-8-oxodecanoyl-1-methoxy-L-tryptophyl-L-isoleucyl-(2R)-2-piperidinecarbonyl] |
BIX-01294 3HCl |
S344-903 |
935693-62-2 |
C28H38N6O2.3HCl |
>98% |
2-(Hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-6,7-dimethoxy-N-[1-(phenylmethyl)-4-piperidinyl]-4-quinazolinamine trihydrochloride |
BML-210 |
H83-904C |
537034-17-6 |
C20H25N3O2 |
98% |
N1-(2-aminophenyl)-N8-phenyloctanediamide |
C-646 |
K311-903 |
328968-36-1 |
C24H19N3O6 |
>98% |
4-[4-[[5-(4,5-Dimethyl-2-nitrophenyl)-2-furanyl]methylene]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzoic acid |
Chaetocin |
K421-904C |
28097-03-2 |
C30H28N6O6S4 |
>99% |
Lys methyltransferase inhibitor |
CPTH2 |
K311-903B |
357649-93-5 |
C14H14ClN3S |
>98% (TLC) |
Cyclopentylidene-[4-(4’-chlorophenyl)thiazol-2-yl]hydrazone |
CUDC-101 |
H83-904 |
1012054-59-9 |
C24H26N4O4 |
>99% (HPLC) |
7-((4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide |
Daminozide |
K421-904B |
1596-84-5 |
C6H12N2O3 |
98% |
1-(2,2-Dimethylhydrazide)butanedioic acid |
Decitabine |
D353-904B |
2353-33-5 |
C8H12N4O4 |
>98% |
5-Aza-2’-deoxycytidine; NSC-127716 |
DMOG |
J48-904 |
89464-63-1 |
C6H9NO5 |
>98% |
N-(2-Methoxy-2-oxoacetyl)glycine methyl ester; Dimethyloxalylglycine |
EX-527 |
S35-904F |
49843-98-3 |
C13H13ClN2O |
98% (TLC) |
6-Chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide (racemic) |
Garcinol |
K311-903C |
78824-30-3 |
C38H50O6 |
>97% (TLC) |
Camboginol, 3-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-1,7-bis(3-methyl-2-buten-1-yl)-5-[(2S)-5-methyl-2-(1-methylethenyl)-4-hexen-1-yl]-bicyclo[3.3.1]non-3-ene-2,9-dione |
GSK-J1 (Free acid) |
J48-904B |
1373422-53-7 |
C22H23N5O2 |
99% |
N-[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-β-alanine |
GSK-J4 (ethylester) |
J48-904C |
1373423-53-0 |
C24H27N5O2 |
>99% |
N-[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-β-alanine ethyl ester |
HPA (HEXYL-4-PENTYNOIC ACID) |
H83-904D |
96017-59-3 |
C11H18O2 |
>97% (TLC) |
2-(2-propynyl)octanoic acid (racemic); HPA |
IOX1 (8H5QCA) |
J48-904D |
5852-78-8 |
C10H7NO3 |
>98% (HPLC) |
5-Carboxy-8-hydroxyquinoline, 8-Hydroxy-5-quinolinecarboxylic acid |
ML-324 |
J48-904E |
1222800-79-4 |
C21H23N3O2 |
>98% (TLC) |
N-(3-(dimethylamino)propyl)-4-(8-hydroxyquinolin-6-yl)benzamide |
MS-275 (Entinostat) |
H83-904E |
209783-80-2 |
C21H20N4O3 |
>98% (TLC) |
Pyridin-3-ylmethyl 4-((2-aminophenyl)carbamoyl)benzylcarbamate; Entinostat |
Panobinostat |
H83-904G |
404950-80-7 |
C21H23N3O2 |
>98% (TLC) |
(E)-N-hydroxy-3-(4-((2-(2-methyl-1H-indol-3-yl)ethylamino)methyl)phenyl) crylamide; LBH-589 |
Phenylbutyrate NA |
H83-904H |
1716-12-7 |
C10H11NaO2 |
>98% (TLC; 5% CH3OH in CH2Cl2, Rf=0.36) |
4-Phenylbutyric acid, sodium salt |
RG-108 |
D353-904C |
48208-26-0 |
C19H14N2O4 |
>98% (TLC) |
N-Phthalyl-L-tryptophan |
Romidepsin (FK228) |
H83-904I |
128517-07-7 |
C24H36N4O6S2 |
>98% (HPLC) |
Cyclo[(2Z)-2-amino-2-butenoyl-L-valyl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenoyl-D-valyl-D-cysteinyl], cyclic (3-5) disulfide |
Sirtinol |
S35-904B |
410536-97-9 |
C26H22N2O2 |
>98% (TLC) |
2-[[(2-Hydroxy-1-naphthalenyl)methylene]amino]-N-(1-phenylethyl)benzamide |
Splitomicin |
S35-904G |
5690-03-09 |
C13H10O2 |
>98% (TLC) |
1,2-Dihydro-3H-naphtho[2,1-b]pyran-3-one |
TC-E 5003 |
P3695-903 |
17328-16-4 |
C16H14Cl2N2O4S |
>98% (TLC) |
N,N’-(Sulfonyldi-4,1-phenylene)bis(2-chloroacetamide) |
Tranylcypromine |
K421-904 |
13492-01-8 |
C9H11N · 1/2H2SO4 |
>98% (TLC) |
Trans (±)-2-phenylcyclopropanamine; 2-PCPA |
Trichostatin A |
H83-904J |
58880-19-6 |
C17H22N2O3 |
>99% |
(2E,4E,6R)-7-(4-(Dimethylamino)phenyl)-N-hydroxy-4,6-dimethyl-7-oxo-2,4-heptadienamide |
Tubastatin A · HCL |
H83-904K |
1239262-52-2 |
C20H21N3O2·HCl |
99% (HPLC) |
N-hydroxy-4-((2-methyl-1,2,3,4-tetrahydropyrido[4,3-b]indol-5-yl)methyl)benzamide hydrochloride |
UNC1999 |
D353-904E |
1431612-23-5 |
C33H43N7O2 |
>98% (HPLC) |
N-[(6-methyl-2-oxo-4-propyl-1H-pyridin-3-yl)methyl]-1-propan-2-yl-6-[6-(4-propan-2-ylpiperazin-1-yl)pyridin-3-yl]indazole-4-carboxamide |
Valproate NA |
H83-904L |
1069-66-5 |
C8H15NaO2 |
>98% (TLC) |
Sodium 2-propylpentanoate |
Vorinostat (SAHA) |
H83-904M |
149647-78-9 |
C14H20N2O3 |
>98% |
N-Hydroxy-N’-phenyloctanediamide |